Neochem Bio Solutions Limited (NSE:NEOCHEM)
India flag India · Delayed Price · Currency is INR
105.00
+0.45 (0.43%)
At close: Nov 16, 2026

Neochem Bio Solutions Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
1,3381,107841.73611.46481.88494.98
Other Revenue
---1.14-0.74
1,3381,107841.73612.6481.88495.72
Revenue Growth
-31.51%37.40%27.13%-2.79%-
Cost of Revenue
952.05768.02571.98394.37328.82-
Gross Profit
385.87338.98269.74218.24153.07495.72
Selling, General & Admin
102.26100.8298.1883.4478.52472.23
Other Operating Expenses
36.0215.2125.9665.3926.96-0
Operating Expenses
151.24128.47137.42161.02117.65483.12
Operating Income
234.64210.51132.3357.2135.4212.6
Interest Expense
-23.31-30.46-31.22-25.12-19.51-
Interest & Investment Income
1.31.30.130.040.060.19
Currency Exchange Gain (Loss)
---0.15--
Other Non Operating Income (Expenses)
-3.8-3.8-2.48-4.48-0.780
EBT Excluding Unusual Items
208.83177.5598.7727.815.1812.79
Gain (Loss) on Sale of Assets
0.460.460.740.18--
Other Unusual Items
-6.19-6.19----
Pretax Income
203.1171.8399.5127.9815.1812.79
Income Tax Expense
59.2151.5625.118.714.463.12
Net Income
143.9120.2774.419.2710.739.67
Net Income to Common
143.9120.2774.419.2710.739.67
Net Income Growth
-61.64%286.10%79.61%10.91%-
Shares Outstanding (Basic)
1614775-
Shares Outstanding (Diluted)
1614775-
Shares Change
34.41%106.74%-26.16%--
EPS (Basic)
8.838.7111.152.892.03-
EPS (Diluted)
8.828.7111.152.892.03-
EPS Growth
--21.86%286.10%42.36%--

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-253.73-198.925.52-90.16-40.72-
Free Cash Flow Per Share
-15.57-14.410.83-13.51-7.70-
Gross Margin
28.84%30.62%32.05%35.63%31.76%100.00%
Operating Margin
17.54%19.02%15.72%9.34%7.35%2.54%
Profit Margin
10.76%10.86%8.84%3.15%2.23%1.95%
Free Cash Flow Margin
-18.96%-17.97%0.66%-14.72%-8.45%-
EBITDA
247.6222.94145.669.4147.5923.49
EBITDA Margin
18.51%20.14%17.30%11.33%9.88%4.74%
D&A For EBITDA
12.9612.4413.2712.212.1710.89
EBIT
234.64210.51132.3357.2135.4212.6
EBIT Margin
17.54%19.02%15.72%9.34%7.35%2.54%
Effective Tax Rate
29.15%30.01%25.23%31.13%29.34%24.39%
Revenue as Reported
1,3551,134861.54620.08487.9495.91
Advertising Expenses
-12.488.27-10.38-